Our team at IBT Bioservices has extensive experience in preclinical testing services to assess the viability and effectiveness of novel therapies against respiratory illnesses such as RSV, influenza, SARS-CoV-2.
None
RSV A2 – Cotton Rat
RSV-A
A2
Long
9320
18537
RSV-B
IBT Bioservices has developed an extensive assortment of reagents to facilitate the advancement of therapeutics and assay development, thus supporting the progress of research on respiratory viruses. We offers a diverse array of products and services designed to facilitate respiratory virus research, ranging from viral proteins to antiserum and antibodies.
Rest assured, our reagents are of exceptional quality, and they are available for purchase to support your research endeavors.
Our in vitro RSV services include antiviral screening assays to identify potential candidates with antiviral activity against RSV. We utilize high-throughput screening techniques to evaluate large compound libraries, natural products, or novel drug candidates for their ability to inhibit viral replication. Our screening assays enable the identification of lead compounds with promising antiviral properties for further development.
Our in vivo RSV services include vaccine evaluation studies using animal models. We assess the immunogenicity and protective efficacy of RSV vaccine candidates, helping you determine their ability to induce robust immune responses and provide protection against RSV infection. We closely monitor key parameters, including viral load, immune response, and behavioral changes, to evaluate the effectiveness of the tested therapies
We provide animal models, such as cotton rats, for studying RSV infection, pathogenesis, and evaluating the efficacy of potential interventions. Our animal models closely mimic the clinical and immunological aspects of RSV infection in humans, providing valuable insights into viral replication in the lungs, host immune responses, disease progression, pathology, and treatment outcomes. Our in vivo models help assess vaccine candidates, antiviral therapies, and evaluate their safety and efficacy.
We work with investigators to determine the best virus model for their therapeutic or vaccine.
At IBT, we offer a wide range of specialized services and expertise in RSV research. Our experienced team of scientists and researchers provide high-quality data, reliable results, and customized solutions to meet your specific research needs. Whether you require in vitro assays to study RSV biology or in vivo studies to evaluate interventions, we are here to support your RSV research and development efforts.Contact us today to discuss your specific RSV service requirements and discover how our expertise can accelerate your research, advance RSV interventions, and contribute to global efforts in combating RSV infections. Together, let’s make strides in RSV research and improve public health outcomes.
